3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
3
Sarcopenia
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Metabolic Syndrome
1
Metabolic Diseases
1
Hormone-receptor-positive Breast Cancer
1
Eunuchism
1
Diabetes Mellitus
1
Cardiovascular Diseases
1
Advanced Prostate Cancer
1
Advanced Breast Cancer
1
Interventions
radium Ra 223 dichloride
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Gonadotropin-Releasing Hormone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Advanced Prostate Cancer
×
Gonadotropin-Releasing Hormone
×
Clear all
NCT02234089
2019-07-05
ProComD
Ferring Pharmaceuticals
Completed
461 enrolled